Highlights in Asthma Therapy From CHEST 2022 Highlights in Asthma Therapy From CHEST 2022

From CHEST 2022, Dr Navitha Ramesh reports key data on biologic therapies for asthma patients, including results from the CLEAR study and trials on omalizumab, benralizumab, and tezepelumab.Medscape
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Pulmonary Medicine ReCAP Source Type: news